FTC settles pay-for-delay lawsuit, files two related complaints

WASHINGTON, Jan 23 (Reuters) - The U.S. Federal Trade

Commission said on Monday it had settled allegations that Endo

Pharmaceuticals violated antitrust law when it agreed

to pay rivals Watson Laboratories and Impax to delay introducing

generic versions of two painkillers.

Read more